Sanitas' 1st-half sales slide down 21%

Lithuanian drugs producer Sanitas recorded sales worth 16.3 million litas ($5.7 million) in the first half of this year, a drop of 21% on the same period last year, according to the LTA news agency. Turnover in June was 27% lower year-on-year at 3.3 million litas.

This diminshed first-half income was attributed to the revision of product prices by the firm's parent company and main customer, Latvian-based Grindeks. However, sales on the domestic market have increased this year and Sanitas is forecasting 38.0 million litas in full-year revenues.